ReconstructionWound careOPCS S57

Negative pressure wound therapy (NPWT)

NPWT ยท vacuum-assisted closure (VACโ„ข) ยท topical negative pressure (TNP)

Negative pressure wound therapy applies subatmospheric pressure (typically โˆ’80 to โˆ’125 mmHg) to a wound through a sealed dressing connected to a vacuum pump and canister. It removes excess interstitial fluid, mechanically deforms the wound edge, and promotes granulation, perfusion and angiogenesis. In skin oncology its main uses are as a bolster over skin grafts, salvage of dehisced reconstruction, downstaging of complex defects pending definitive reconstruction, and management of post-lymphadenectomy seroma / drainage.

CurrentLast reviewed 16 May 2026

Mechanism

  • Subatmospheric pressure (typically โˆ’80 to โˆ’125 mmHg) at the wound bed.
  • Macrostrain: contraction of the wound bed; reduces volume of large defects.
  • Microstrain: mechanical deformation of cells โ†’ mechanotransduction-driven proliferation and angiogenesis.
  • Removal of exudate and interstitial oedema.
  • Reduction of bacterial bioburden (limited evidence; not a substitute for surgical debridement).
  • Stabilisation of the wound bed โ†’ improved graft / flap take.

Indications in skin oncology

  • Skin-graft bolster: over uneven, large or contoured beds (lower limb, scalp, perineal); reduces shear and seroma. NPWT bolster typically applied for 5-7 days.
  • Salvage of dehisced wounds or seroma after lymphadenectomy.
  • Temporary closure of large defects awaiting Mohs / permanent paraffin margin clearance.
  • Post-operative seroma prevention after groin / axillary block dissection โ€” supported by RCTs in melanoma and other oncologic dissections.
  • Dehiscence over irradiated beds; complex pressure-injury management in advanced disease.
  • Bridging therapy between staged reconstructions.

Parameters and dressings

  • Pressure: usually โˆ’125 mmHg continuous for adults; โˆ’75 to โˆ’100 mmHg over fragile / elderly skin or grafts; โˆ’50 to โˆ’75 mmHg for paediatric and ischaemic limbs.
  • Mode: continuous (most common); intermittent (3-minutes-on / 2-minutes-off) cycles may promote granulation but discomfort limits use.
  • Foam: black polyurethane (open-cell, hydrophobic โ€” most aggressive granulation); white polyvinyl alcohol (denser, less granulation, used over tendons / fragile tissue).
  • Gauze NPWT: alternative; less aggressive granulation; favoured by some over exposed structures.
  • Instillation NPWT (NPWT-i): cyclical instillation of saline / antiseptic between negative-pressure periods; useful in heavily contaminated / infected wounds.
  • Dressing change every 2-3 days for foam systems.

Contraindications and complications

Contraindications:

  • Untreated osteomyelitis.
  • Necrotic tissue with eschar (debride first).
  • Malignancy in the wound bed (relative; oncology team decision).
  • Exposed major vessels / vascular anastomosis without protective barrier.
  • Coagulopathy / active bleeding.
  • Allergy to dressing components.

Complications:

  • Pain on initiation (consider warming saline soak or pressure step-down).
  • Periwound dermatitis; skin maceration.
  • Bleeding (rare but reported โ€” especially after anticoagulation, infection, vessel exposure).
  • Retained foam.
  • Tissue ingrowth โ€” use non-adherent contact layer over fragile tissues, friable grafts, or paediatric skin.

Evidence and UK practice

  • Skin grafts: meta-analyses show improved graft take and reduced complications with NPWT bolster (vs conventional bolster) โ€” particularly for lower-limb and meshed grafts.
  • Lymphadenectomy seroma: RCTs of prophylactic NPWT after groin / axillary dissection in melanoma show ~40-50% reduction in seroma rate.
  • NICE: HTG509 (formerly MTG43; PICO single-use NPWT for closed surgical incisions) supports prophylactic use over high-risk closed incisions.
  • NPWT is incorporated in BAPRAS / NHS major-trauma and complex skin-cancer reconstruction pathways.

References

  1. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38:563-577.
  2. Webster J et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2019;3:CD009261.
  3. Schaverien MV et al. Negative pressure wound therapy following inguinal lymphadenectomy: a systematic review and meta-analysis. J Surg Oncol. 2020;121:846-855.
  4. NICE HTG509. PICO negative pressure wound dressings for closed surgical incisions. London: NICE; 2019 (formerly MTG43; last reviewed 29 February 2024).
  5. WUWHS. Consensus document: closed surgical incision management. London: Wounds International; 2016.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.